Brevan Howard Capital Management »

Denali Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $365k 18k 20.38
2024-09-30 $325k 11k 29.13
2024-06-30 $682k 29k 23.22

More positions owned by Brevan Howard Capital Management

Select Sector Spdr Tr Financial (XLF)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Newmont Mining Corporation Call Option (NEM)
Select Sector Spdr Tr Technology Call Option (XLK)

View all positions for Brevan Howard Capital Management

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Vanguard Group
Wellington Management Company
FMR
Capital Research Global Investors
Temasek Holdings
State Street Corporation
Crestline Management
Baker Bros. Advisors
Ubs Global Asset Management Americas
Alliancebernstein
T. Rowe Price Associates
Geode Capital Management
Camber Capital Management

View all funds holding Denali Therapeutics